Clinical trial
UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid…
NCT00006464 · City of Hope Medical Center, Other · Completed
Key facts
| NCT number | NCT00006464 |
|---|---|
| Title | UCN-01 and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors |
| Official title | Phase I Dose Escalation Study of UCN-01 (NSC 638850) Plus Cisplatin in Advanced Malignant Solid Tumors |
| Lead sponsor | City of Hope Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | 7-hydroxystaurosporine, cisplatin |
| Start date | Mar 1, 2001 |
| Primary completion | Jan 1, 2005 |
| Completion | Jun 1, 2008 |
| First posted | May 30, 2003 |
| Last update posted | Jan 15, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: